Back
Range Cancer Therapeutics ETF Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.50
Seasonality Move:
-2.75%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- The current trend is moderately bullish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.64 | Buy |
| 20-day SMA: | 15.16 | Buy |
| 50-day SMA: | 14.87 | Buy |
| 200-day SMA: | 14.75 | Buy |
| 8-day EMA: | 15.55 | Buy |
| 20-day EMA: | 15.22 | Buy |
| 50-day EMA: | 14.9 | Buy |
| 200-day EMA: | 14.45 | Buy |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 58.29 | Buy |
| Chaikin Money Flow: | 4125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.57 - 15.57) | Buy |
| Bollinger Bands (100): | (13.97 - 15.41) | Buy |
Range Cancer Therapeutics ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 15.69 while CNCR 8-day simple moving average is 15.64, which is a Buy signal.
- The stock price of CNCR is 15.69 while Range Cancer Therapeutics ETF 20-day SMA is 15.16, which makes it a Buy.
- Range Cancer Therapeutics ETF 50-day simple moving average is 14.87 while CNCR share price is 15.69, making it a Buy technically.
- CNCR stock price is 15.69 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.75, creating a Buy signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a Sell
The current Range Cancer Therapeutics ETF [CNCR] share price is $15.69. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
15.69
Share Volume:
6.01K
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
9.22
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?
The Range Cancer Therapeutics ETF stock price is 15.69 USD today. -
Will CNCR stock go up or go down?
Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators -
Is Range Cancer Therapeutics ETF overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 15.69 while CNCR 8-day exponential moving average is 15.55, which is a Buy signal.
- The stock price of CNCR is 15.69 while Range Cancer Therapeutics ETF 20-day EMA is 15.22, which makes it a Buy.
- Range Cancer Therapeutics ETF 50-day exponential moving average is 14.90 while CNCR share price is 15.69, making it a Buy technically.
- CNCR stock price is 15.69 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.45, creating a Buy signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
- CNCR Moving Average Covergence Divergence (MACD) indicator is 0.31, suggesting Range Cancer Therapeutics ETF is a Buy
- Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 58.29, which suggest Range Cancer Therapeutics ETF is overbought
- The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (14.57 - 15.57), which suggest Range Cancer Therapeutics ETF is a Buy
- The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (13.97 - 15.41), which suggest Range Cancer Therapeutics ETF is a Buy
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.